Patents by Inventor John OHD

John OHD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Base-modified cytidine nucleotides for leukemia therapy
    Patent number: 12479870
    Abstract: Compounds of the formula I wherein X is a bond or —CH2, and pharmaceutically acceptable salts thereof are useful in the parenteral treatment of leukemia, myelodysplastic syndrome or lymphoma, especially in patients presenting with cytarabine resistance and/or over 60 years of age.
    Type: Grant
    Filed: May 21, 2024
    Date of Patent: November 25, 2025
    Assignee: MEDIVIR AB
    Inventors: Pedro Pinho, Björn Klasson, John Ohd, Mark Albertella
  • Base-Modified Cytidine Nucleotides for Leukemia Therapy
    Publication number: 20240309031
    Abstract: Compounds of the formula I wherein X is a bond or —CH2, and pharmaceutically acceptable salts thereof are useful in the parenteral treatment of leukemia, myelodysplastic syndrome or lymphoma, especially in patients presenting with cytarabine resistance and/or over 60 years of age.
    Type: Application
    Filed: May 21, 2024
    Publication date: September 19, 2024
    Inventors: Pedro PINHO, Björn KLASSON, John OHD, Mark ALBERTELLA
  • Base-Modified Cytidine Nucleotides for Leukemia Therapy
    Publication number: 20210261584
    Abstract: Compounds of the formula I wherein X is a bond or —CH2, and pharmaceutically acceptable salts thereof are useful in the parenteral treatment of leukemia, myelodysplastic syndrome or lymphoma, especially in patients presenting with cytarabine resistance and/or over 60 years of age.
    Type: Application
    Filed: June 20, 2019
    Publication date: August 26, 2021
    Inventors: Pedro PINHO, Björn KLASSON, John OHD, Mark ALBERTELLA